Discovery of next generation A3 adenosine receptor selective agonists for treatment of chronic neuropathic pain

被引:0
|
作者
Tosh, Dilip K. [1 ]
Paoletta, Silvia [1 ]
Ford, Amanda [2 ]
Janes, Kali [2 ]
Salvemini, Daniela [2 ]
Jacobson, Kenneth A. [1 ]
机构
[1] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
71-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists
    Tosh, Dilip K.
    Ciancetta, Antonella
    Warnick, Eugene
    O'Connor, Robert
    Chen, Zhoumou
    Gizewski, Elizabeth
    Crane, Steven
    Gao, Zhan-Guo
    Auchampach, John A.
    Salvemini, Daniela
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3249 - 3263
  • [42] D-4′-thioadenosine derivatives as highly potent and selective agonists at the human A3 adenosine receptor
    Lee, HW
    Shin, DH
    Jeong, JY
    Kim, HO
    Chun, MW
    Melman, N
    Gao, ZG
    Jacobson, KA
    Jeong, LS
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7): : 607 - 609
  • [43] Assessment of cardioprotective efficacy of A3 adenosine receptor agonists using mice with cardiac-specific deletion of the A3 adenosine receptor gene
    Wan, Tina
    Tampo, Akihito
    Kwok, Wai-Meng
    Auchampach, John
    PURINERGIC SIGNALLING, 2014, 10 (04) : 794 - 794
  • [44] Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors
    Varani, K
    Cacciari, B
    Baraldi, PG
    Dionisotti, S
    Ongini, E
    Borea, PA
    LIFE SCIENCES, 1998, 63 (05) : PL81 - PL87
  • [45] Synthesis of new adenosine analogues derivatives of allofuranose as potential adenosine A3 receptor agonists
    Teran, Carmen
    Besada, Pedro
    Perez-Castillo, Yunierkis
    Teijeira, Marta
    PURINERGIC SIGNALLING, 2010, 6 (01) : 112 - 112
  • [46] A3 adenosine receptor agonists reverse established oxaliplatin-induced neuropathic pain through an IL-10 mediated mechanism of action in spinal cord
    Maloy, C.
    Janes, K.
    Bryant, L.
    Tosh, D.
    Jacobson, K.
    Salvemini, D.
    JOURNAL OF PAIN, 2014, 15 (04): : S60 - S60
  • [47] Resistance of muscle to tumor metastases: A role for A3 adenosine receptor agonists
    Bar-Yehuda, S
    Barer, F
    Volfsson, L
    Fishman, P
    NEOPLASIA, 2001, 3 (02): : 125 - 131
  • [48] Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
    Seltzman, Herbert H.
    Shiner, Craig
    Hirt, Erin E.
    Gilliam, Anne F.
    Thomas, Brian F.
    Maitra, Rangan
    Snyder, Rod
    Black, Sherry L.
    Patel, Purvi R.
    Mulpuri, Yatendra
    Spigelman, Igor
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (16) : 7525 - 7543
  • [49] Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain
    Loram, Lisa C.
    Harrison, Jacqueline A.
    Sloane, Evan M.
    Hutchinson, Mark R.
    Sholar, Paige
    Taylor, Frederick R.
    Berkelhammer, Debra
    Coats, Benjamen D.
    Poole, Stephen
    Milligan, Erin D.
    Maier, Steven F.
    Rieger, Jayson
    Watkins, Linda R.
    JOURNAL OF NEUROSCIENCE, 2009, 29 (44): : 14015 - 14025
  • [50] Novel neuronal nicotinic receptor selective compounds for the treatment of acute, chronic and neuropathic pain
    Lippiello, P. M.
    Gatto, G. J.
    Jordan, K. G.
    Bencherif, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S252 - S252